A therapist sees 25 patients a week and is still using a physical notebook.
46 practices already work differently.
01
Problem
1.5 h
That is how much time every day case analysis, conceptualisation and documentation take. From memory, in the evening, unpaid.
02
Insight
Therapists want to use AI. They have no safe tool for patient data.
Professional confidentiality and GDPR. We are that tool: safe, and inside the method they already work in.
03
Product
A session recording becomes clinical material. One session, and the whole process.
Conceptualisation
a picture of the patient built from their own words
Clinical annotations
cognitive distortions marked in the transcript
Continuity of process
patient progress across months
04
Why now
For years there was no law and no software. A law regulating the psychologist profession is coming in.
Regulation has to be followed by infrastructure. Other medical professions already have it. Whoever gathers the data and the community first, wins.
05
Traction · five months of selling
46
paying therapists
13k
PLN net MRR · +42% MoM
<1%
churn: a therapist will not give up what they built with a patient
Net MRR at month end, PLN · Aug = as of 28.08
06
Potential
200,000 therapists × 270 PLN/month = 650M PLN a year. The wedge alone.
Today · Poland
46
paying, 5 countries organically
18 months · DACH · UK · NL
500+
paying, 3 markets
5% of the EU market
30M PLN
ARR · a path to 100M
07
Why we win
Others shorten the notes. We see the whole therapy process.
Annotated sessions, a supervisor on the team, class I medical device. You do not copy that over a weekend.
saves time →
depth of process →
Therapy Support
Upheal · Mentalyc
Med-scribes
Lyssn
Practice management software
08
Team
A clinician, a security engineer and a CEO who sold the first licences himself.
Joanna Głowacka
CBT supervisor
Clinically audits every feature. Our unfair advantage.
Bohdan Głowacki
CTO
Security and architecture; systems built for the Ministry of Finance, among others.
Bartłomiej Głowacki
CEO
100% of his time on sales and capital. A team of 7, including a Tech Lead from MetaMask.
09
Ask
2M PLN to enter 3 markets and B2B practices within 18 months.
500+ paying · multi-therapist practices · break-even without a Series A. 1.05M PLN in grants already in the bank. Product-market fit confirmed. The only question is how fast we scale.
A1 · Unit economics (3-year model, year 1 → year 3)
Year 1
Year 3
CAC
1,520 PLN
554 PLN
LTV / CAC
3,9×
12,3×
CAC payback
5.1 mo
1.6 mo
Paying · revenue / year
341 · 730k PLN
1,438 · 4.56M PLN
Break-even
month 26 · peak cash need 1.96M PLN
A1
A2 · Today in numbers (Stripe LIVE, 28.08.2026)
46 paying, 29 in trial · ARPU 263 PLN net (342 PLN list price, 70% on a −30% beta discount)
Churn produktowy <1%/mies. · summer cancellations are a holiday from the subscription, customers come back (2 of 7 already did) · net MRR ×6.6 since March, CMGR +42%
Trial conversion 41% with 1:1 onboarding (10% without) · 100% of deals closed by phone
8,200 sessions processed, 1,740 in the last 30 days · 1,370 patients · AI cost down 23×
A2
A3 · Sales channel
~400 phone calls / week (one dedicated person); 36% of customers come from webinars
Webinars are run by an AI agent: last one 205 sign-ups, 77 live, 70 stayed to the end; 14 PLN per lead
CBT conferences: one conference = 46 trials; 5 events in 4 countries by year end, mailing to 89k EABCT members
Microsoft ISV Success: first-party Marketplace listing + medical facility list
A3
A4 · Regulation and data
MDR 2017/745, Class I (SaMD), Rule 11, no notified body · SRN issued by the Polish medicines agency · 28 technical documents · PRRC
AI Act: outside the high-risk category (art. 6(1)) · the therapist approves every output
GDPR: data encrypted and processed in the EU, the therapist is the controller, processing agreement in place
External legal opinion in the data room
A4
A5 · Round and grants
2M PLN / 18 months: lead investor 200k EUR (first tranche) + industry co-investor 1.13M PLN (month 6, after a sales milestone)
